Table 2.
Salivary gland function and dental examination of children at different stages of chronic kidney disease (CKD) and healthy controls.
| Control n = 30 |
Stage 1 n = 5 |
Stage 2 n = 8 |
Stage 3 n = 7 |
Stage 4 n = 5 |
Stage 5 n = 5 |
CKD n = 30 |
ANOVA p |
|
|---|---|---|---|---|---|---|---|---|
| Total protein NWS (μg/mL) | 1371 ± 78.52 | 832.2 ± 31.45 * | 976 ± 46.75 * | 931.1 ± 89.26 * | 919.5 ± 52.16 | 897.7 ± 72.63 * | 918.4 ± 29.07 * | <0.001 |
| Total protein SWS (μg/mL) | 1308 ± 30.77 | 907.1 ± 89.52 * | 916.3 ± 64.24 * | 1031 ± 64.17 * | 998.9 ± 40.09 * | 890.1 ± 78.15 * | 950.9 ± 30.56 * | <0.001 |
| NWS flow rate (mL/min) | 0.56 ± 0.02 | 0.30 ± 0.03 * | 0.34 ± 0.04 * | 0.33 ± 0.03 * | 0.24 ± 0.05 * | 0.31 ± 0.08 * | 0.31 ± 0.02 * | <0.001 |
| SWS flow rate (mL/min) | 1.42 ± 0.05 * | 0.85 ± 0.09 * | 0.78 ± 0.1 * | 0.76 ± 0.1 * | 0.81 ± 0.12 * | 1.09 ± 0.08 | 0.84 ± 0.05 * | <0.001 |
| DMFT | 3.2 ± 0.5 | 3.1 ± 0.4 | 3.0 ± 0.7 | 3.2 ± 0.3 | 3.6 ± 0.8 | 3.5 ± 0.5 | 3.3 ± 0.5 | NS |
| dmft | 10.1 ± 0.5 | 10.8 ± 0.2 | 11 ± 0.2 | 12.5 ± 0.3 | 11.1 ± 0.5 | 12.4 ± 0.8 | 11.5 ± 0.4 | NS |
| PBI | 0 ± 0.1 | 0 ± 0.1 | 0 ± 0.3 | 0 ± 0.3 | 0 ± 0.3 | 0 ± 0.3 | 0 ± 0.3 | NS |
| GI | 0 ± 0.2 | 0 ± 0.2 | 0 ± 01 | 0 ± 0.2 | 0 ± 0.2 | 0 ± 0.2 | 0 ± 0.2 | NS |
DMFT—decay, missing, filled teeth; GI—Gingival Index; NWS—non-stimulated whole saliva; SWS—stimulated whole saliva. * p < 0.05 vs. the control group.